Navigation Links
BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label
Date:12/17/2009

FLORHAM PARK, N.J., Dec. 17 /PRNewswire/ -- BASF today announced that the Environmental Protection Agency (EPA) has approved the use of Aseptrol® S10 - Tab in H1N1 sanitization operations in institutional and industrial facilities, such as, schools, hospitals, government buildings, retail and restaurants, and recreational facilities. Aseptrol S10 - Tab is based on Chlorine dioxide (CIO2) release technology.

"Aseptrol S10 - Tab delivers a broad spectrum disinfectant as stated in the EPA label and kills a large number of pathogens, such as H1N1 virus, Avian Influenza A (H3N2), Influenza A, and HIV, on contact surfaces," said Gary Dee, Business Director, Home and Personal Care, Care Chemicals North America at BASF. "The tablet is stable when dry and is packed in foil pouches, saving energy and reducing overall logistics costs."

High efficiency CIO2 is formed in the pores of the tablet when immersed in water. As the tablet dissolves, this powerful oxidizer disperses into the bulk solution. Using the Aseptrol S10 - Tab is as easy as Drop, Spray and Wipe: Drop the tablet in a spray bottle containing water, spray it evenly on a non-porous surface and wipe the surface until dry. Treated surfaces must remain wet for 10 minutes (or 30 minutes for Foot and Mouth Disease Virus). The solution does not leave a residue.

Care Chemicals and Formulators

BASF's Care Chemicals division develops, produces and markets a comprehensive range of products for nutrition, pharmaceuticals, cosmetics, detergents & cleaners, and industrial & chemical applications. As a result of focused research and development, we are a preferred partner of our customers worldwide.

The products offered by BASF Care Chemicals include vitamins, carotenoids, organic acids, active pharmaceutical ingredients and excipients, aroma chemicals and cosmetic ingredients, chelating agents, surfactants, biocides, waxes and wax emulsions as well as metal surface treatment products.

BASF - The Chemical Company. We don't make a lot of the products you buy. We make a lot of the products you buy better.®

BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has more than 15,000 employees in North America, and had sales of approximately $17.5 billion in 2008. For more information about BASF's North American operations, or to sign up to receive news releases by e-mail, visit www.basf.com/usa.

BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics and performance products to agricultural products, fine chemicals and oil and gas. As a reliable partner, BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF posted sales of more than euro 62 billion in 2008 and had approximately 97,000 employees as of the end of the year. Further information on BASF is available on the Internet at www.basf.com.

Aseptrol S10 - Tab is a registered trademark of BASF Corporation.

SOURCE BASF Corporation


'/>"/>
SOURCE BASF Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CareCentrix Receives URAC Health Utilization Management Accreditation
2. Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
3. SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System
4. Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets
5. EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution
6. Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award
7. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
8. Greenway Medical Technologies PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification
9. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
10. Mylan Receives Approval for Generic Version of Antiepileptic Keppra(R) 1000 mg
11. Dynatronics Receives 180-Day NASDAQ Extension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... latest in wound care advancements to physician colleagues, skilled nursing facility medical directors ... "Navigating the Treacherous Waters of Wound Care." , "At many of these conferences ...
Breaking Medicine News(10 mins):